# Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

> **NCT04389541** · — · COMPLETED · sponsor: **iOMEDICO AG** · enrollment: 499 (actual)

## Conditions studied

- Advanced Solid Tumors or Hematologic Malignancies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04389541
- **Lead sponsor:** iOMEDICO AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-17
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 499 (ACTUAL)
- **Last updated:** 2023-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04389541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04389541, "Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04389541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*